Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuandu Hanbi liquid (鸢都寒痹液) is a traditional Chinese medicine (TCM) oral solution developed and marketed by Shandong Wohua Pharmaceutical Co., Ltd. It is specifically indicated for the treatment of musculoskeletal disorders, particularly cold-type arthralgia and joint pain within the orthopedic field. As a TCM formulation, it likely comprises a complex mixture of herbal extracts intended to dispel cold and alleviate pain, though its specific active ingredients and molecular targets are not publicly disclosed. It is currently approved and marketed in China as part of Shandong Wohua's portfolio of TCM products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yuandu Hanbi liquid.